151 related articles for article (PubMed ID: 36297584)
1. Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A
Kiong J; Nahar UJ; Jin S; Shalash AO; Zhang J; Koirala P; Khalil ZG; Capon RJ; Skwarczynski M; Toth I; Hussein WM
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297584
[TBL] [Abstract][Full Text] [Related]
2. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A
Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM
ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053
[TBL] [Abstract][Full Text] [Related]
3. Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A
Zhao L; Jin W; Cruz JG; Marasini N; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32357402
[TBL] [Abstract][Full Text] [Related]
4. A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus: Lipidation and polyelectrolyte complexes.
Zhao L; Yang J; Nahar UJ; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
Bioorg Med Chem; 2020 Dec; 28(24):115823. PubMed ID: 33120079
[TBL] [Abstract][Full Text] [Related]
5. Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct.
Olive C; Batzloff M; Horváth A; Clair T; Yarwood P; Toth I; Good MF
Indian J Med Res; 2004 May; 119 Suppl():88-94. PubMed ID: 15232170
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.
Hayman WA; Toth I; Flinn N; Scanlon M; Good MF
Immunol Cell Biol; 2002 Apr; 80(2):178-87. PubMed ID: 11940119
[TBL] [Abstract][Full Text] [Related]
7. Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus.
Yang J; Firdaus F; Azuar A; Khalil ZG; Marasini N; Capon RJ; Hussein WM; Toth I; Skwarczynski M
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066099
[TBL] [Abstract][Full Text] [Related]
8. A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.
Olive C; Batzloff MR; Horváth A; Wong A; Clair T; Yarwood P; Toth I; Good MF
Infect Immun; 2002 May; 70(5):2734-8. PubMed ID: 11953422
[TBL] [Abstract][Full Text] [Related]
9. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.
Olive C; Clair T; Yarwood P; Good MF
Vaccine; 2002 Jun; 20(21-22):2816-25. PubMed ID: 12034109
[TBL] [Abstract][Full Text] [Related]
10. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant.
Nahar UJ; Wang J; Shalash AO; Lu L; Islam MT; Alharbi N; Koirala P; Khalil ZG; Capon RJ; Hussein WM; Toth I; Skwarczynski M
Vaccine; 2024 Jun; ():. PubMed ID: 38897890
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol as an inbuilt immunoadjuvant for a lipopeptide vaccine against group A Streptococcus infection.
Alharbi N; Shalash AO; Koirala P; Boer JC; Hussein WM; Khalil ZG; Capon RJ; Plebanski M; Toth I; Skwarczynski M
J Colloid Interface Sci; 2024 Jun; 663():43-52. PubMed ID: 38387185
[TBL] [Abstract][Full Text] [Related]
13. Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
Marasini N; Khalil ZG; Giddam AK; Ghaffar KA; Hussein WM; Capon RJ; Batzloff MR; Good MF; Skwarczynski M; Toth I
Int J Pharm; 2016 Nov; 513(1-2):410-420. PubMed ID: 27659862
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity Assessment of Cell Wall Carbohydrates of Group A
Khatun F; Dai CC; Rivera-Hernandez T; Hussein WM; Khalil ZG; Capon RJ; Toth I; Stephenson RJ
ACS Infect Dis; 2021 Feb; 7(2):390-405. PubMed ID: 33533246
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of lipid, cyclic peptide and antigen rearrangement of physically mixed vaccines.
Huang W; Madge HYR; Zhang J; Gilmartin L; Hussein WM; Khalil ZG; Koirala P; Capon RJ; Toth I; Stephenson RJ
Int J Pharm; 2022 Apr; 617():121614. PubMed ID: 35245637
[TBL] [Abstract][Full Text] [Related]
16. New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus.
Norpi ASM; Nordin ML; Ahmad N; Katas H; Fuaad AAA; Sukri A; Marasini N; Azmi F
Asian J Pharm Sci; 2022 May; 17(3):435-446. PubMed ID: 35782331
[TBL] [Abstract][Full Text] [Related]
17. Opsonic Activity of Conservative Versus Variable Regions of the Group A
Dai C; Khalil ZG; Hussein WM; Yang J; Wang X; Zhao L; Capon RJ; Toth I; Stephenson RJ
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32392777
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.
Nevagi RJ; Dai W; Khalil ZG; Hussein WM; Capon RJ; Skwarczynski M; Toth I
Eur J Med Chem; 2019 Oct; 179():100-108. PubMed ID: 31247372
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.
Caro-Aguilar I; Ottinger E; Hepler RW; Nahas DD; Wu C; Good MF; Batzloff M; Joyce JG; Heinrichs JH; Skinner JM
Hum Vaccin Immunother; 2013 Mar; 9(3):488-96. PubMed ID: 23249976
[TBL] [Abstract][Full Text] [Related]
20. Active immunisation of mice with GnRH lipopeptide vaccine candidates: Importance of T helper or multi-dimer GnRH epitope.
Goodwin D; Simerska P; Chang CH; Mansfeld FM; Varamini P; D'Occhio MJ; Toth I
Bioorg Med Chem; 2014 Sep; 22(17):4848-54. PubMed ID: 25059504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
